175135-22-5 Usage
Description
2-(N-PROPYLTHIO)NICOTINIC ACID, also known as 2-(Propylthio)nicotinic Acid, is an organic compound with the molecular formula C9H11NO2S. It is characterized by the presence of a thioether group attached to a nicotinic acid structure, which contributes to its unique chemical properties and potential applications in various fields.
Uses
Used in Pharmaceutical Industry:
2-(N-PROPYLTHIO)NICOTINIC ACID is used as a reagent for the synthesis of product inhibitors of glucose transporters 1 and 3. These inhibitors play a crucial role in regulating glucose uptake in cells, which can be beneficial for the development of treatments targeting conditions such as diabetes and obesity. By modulating glucose transporter activity, this compound can contribute to the advancement of therapeutic strategies for these metabolic disorders.
Check Digit Verification of cas no
The CAS Registry Mumber 175135-22-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,7,5,1,3 and 5 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 175135-22:
(8*1)+(7*7)+(6*5)+(5*1)+(4*3)+(3*5)+(2*2)+(1*2)=125
125 % 10 = 5
So 175135-22-5 is a valid CAS Registry Number.
InChI:InChI=1/C9H11NO2S/c1-2-6-13-8-7(9(11)12)4-3-5-10-8/h3-5H,2,6H2,1H3,(H,11,12)/p-1
175135-22-5Relevant articles and documents
Novel compounds comprising thionicotinamide scaffold, its enantiomers, its diastereomers or its pharmaceutically acceptable salt and antiviral composition containing the same as an active ingredient
-
Paragraph 0101-0104, (2018/05/16)
The present invention relates to a novel compound including a thionicotinamide scaffold, an enantiomer thereof, a diastereomer or a pharmaceutically acceptable salt, and antiviral composition containing the same as an active ingredient. According to the present invention, the novel compound which is represented by chemical formula 1 exhibits remarkably excellent antiviral activities against influenza virus, and barely causes side effects due to low cytotoxicity. Thus, the pharmaceutical composition containing the same as the active ingredient can be useful for preventing or treating diseases caused by influenza virus infection.COPYRIGHT KIPO 2018